Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1262
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Review of local injection of anti-TNF for perianal fistulising Crohn’s disease ; volume:32 ; number:11 ; day:12 ; month:9 ; year:2017 ; pages:1539-1544 ; date:11.2017
International journal of colorectal disease ; 32, Heft 11 (12.9.2017), 1539-1544, 11.2017
- Urheber
-
Adegbola, Samuel O.
- Beteiligte Personen und Organisationen
-
Sahnan, Kapil
Tozer, Philip J.
Phillips, Robin KS
Faiz, Omar D.
Warusavitarne, Janindra
Hart, Ailsa
SpringerLink (Online service)
- DOI
-
10.1007/s00384-017-2899-0
- URN
-
urn:nbn:de:1111-201711155637
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Adegbola, Samuel O.
- Sahnan, Kapil
- Tozer, Philip J.
- Phillips, Robin KS
- Faiz, Omar D.
- Warusavitarne, Janindra
- Hart, Ailsa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
Insights into treatment of complex Crohn's perianal fistulas
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients
Insights into treatment of complex Crohn's perianal fistulas
Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients
Stopping Anti-TNF in Crohn’s Disease Remitters: Pros and Cons: The Pros
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial
Adenocarcinoma Arising from Perianal Fistulizing Crohn’s Disease
Complex perianal fistulas in Crohn's disease
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
MRI characteristics of proctitis in Crohn’s disease on perianal MRI
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients